NASDAQ: OXBROxbridge Re Holdings Ltd Stock
$0.96+0.08 (+9.09%)
Updated Jun 12, 2026
OXBR Price
$0.96
Fair Value Price
$0.76
Market Cap
$7.79M
52 Week Low
$0.66
52 Week High
$2.86
P/E
-3.85x
P/B
1.29x
P/S
3.67x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.51M
Earnings
-$1.92M
Gross Margin
-19.2%
Operating Margin
-76.48%
Profit Margin
-76.5%
Debt to Equity
0.35
Operating Cash Flow
-$1M
Beta
1.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
OXBR Overview
Oxbridge Re Holdings Limited, along with its various subsidiaries, specializes in offering tailored property and casualty reinsurance coverage. This protection is chiefly provided for property and liability insurance carriers operating predominantly within the Gulf Coast area of the United States. The company channels its offerings to clients exclusively through the services of reinsurance brokers. Founded in 2013, Oxbridge Re Holdings Limited's primary corporate base is located in George Town, Cayman Islands.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine OXBR's potential to beat the market
- OXBR doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Reinsurance Insurance
Industry Rating
B
OXBR
RankedUnranked of 7
RankedUnranked of 7
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $210.45 | B | |
| $31.90 | B | |
| $23.38 | C |
Be the first to know about important OXBR news, forecast changes, insider trades & much more!
OXBR News
Overview
Due Diligence Score
–
Industry Average (35)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OXBR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OXBR ($0.96) is overvalued by 27.19% relative to our estimate of its Fair Value price of $0.76 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
OXBR ($0.96) is not significantly undervalued (27.19%) relative to our estimate of its Fair Value price of $0.76 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
OXBR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more OXBR due diligence checks available for Premium users.
Valuation
OXBR fair value
Fair Value of OXBR stock based on Discounted Cash Flow (DCF)
Price
$0.96
Fair Value
$0.76
Overvalued by
26.93%
OXBR ($0.96) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
OXBR ($0.96) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
OXBR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
OXBR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-3.85x
Industry
12.34x
Market
14.15x
OXBR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.29x
Industry
0.99x
OXBR is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
OXBR's financial health
Profit margin
Revenue
$623.0k
Net Income
$22.0k
Profit Margin
3.5%
OXBR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$8.7M
Liabilities
$2.1M
Debt to equity
0.35
OXBR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
OXBR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$210.0k
Investing
$0.0
Financing
$1.0M
OXBR vs Reinsurance Insurance Stocks
Oxbridge Re Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.